Northern Trust’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.9K | Sell |
8,908
-25,683
| -74% | -$190K | ﹤0.01% | 4189 |
|
|
2025
Q1 | $298K | Sell |
34,591
-2,597
| -7% | -$22.3K | ﹤0.01% | 3792 |
|
|
2024
Q4 | $1.33M | Sell |
37,188
-152
| -0.4% | -$5.43K | ﹤0.01% | 3247 |
|
|
2024
Q3 | $1.76M | Buy |
37,340
+1,315
| +4% | +$62.1K | ﹤0.01% | 3080 |
|
|
2024
Q2 | $1.81M | Sell |
36,025
-1,782
| -5% | -$89.5K | ﹤0.01% | 2952 |
|
|
2024
Q1 | $4.23M | Buy |
37,807
+551
| +1% | +$61.7K | ﹤0.01% | 2577 |
|
|
2023
Q4 | $2.16M | Sell |
37,256
-3,967
| -10% | -$230K | ﹤0.01% | 2962 |
|
|
2023
Q3 | $1.31M | Sell |
41,223
-2,741
| -6% | -$87K | ﹤0.01% | 3174 |
|
|
2023
Q2 | $3.62M | Buy |
43,964
+8,579
| +24% | +$706K | ﹤0.01% | 2679 |
|
|
2023
Q1 | $3.64M | Sell |
35,385
-790
| -2% | -$81.2K | ﹤0.01% | 2644 |
|
|
2022
Q4 | $5.3M | Buy |
36,175
+1,286
| +4% | +$188K | ﹤0.01% | 2451 |
|
|
2022
Q3 | $5.9M | Buy |
34,889
+630
| +2% | +$106K | ﹤0.01% | 2367 |
|
|
2022
Q2 | $3.96M | Buy |
34,259
+5,289
| +18% | +$611K | ﹤0.01% | 2651 |
|
|
2022
Q1 | $2.89M | Sell |
28,970
-945
| -3% | -$94.3K | ﹤0.01% | 2901 |
|
|
2021
Q4 | $4.65M | Buy |
29,915
+2,034
| +7% | +$316K | ﹤0.01% | 2725 |
|
|
2021
Q3 | $6.57M | Buy |
27,881
+574
| +2% | +$135K | ﹤0.01% | 2564 |
|
|
2021
Q2 | $9.27M | Buy |
27,307
+3,578
| +15% | +$1.21M | ﹤0.01% | 2421 |
|
|
2021
Q1 | $9.6M | Sell |
23,729
-1,533
| -6% | -$620K | ﹤0.01% | 2321 |
|
|
2020
Q4 | $16.8M | Sell |
25,262
-159
| -0.6% | -$106K | ﹤0.01% | 1918 |
|
|
2020
Q3 | $11.8M | Buy |
25,421
+16,387
| +181% | +$7.63M | ﹤0.01% | 2005 |
|
|
2020
Q2 | $5.29M | Sell |
9,034
-7,100
| -44% | -$4.15M | ﹤0.01% | 2485 |
|
|
2020
Q1 | $2.35M | Buy |
16,134
+589
| +4% | +$85.8K | ﹤0.01% | 2765 |
|
|
2019
Q4 | $2.23M | Buy |
15,545
+10
| +0.1% | +$1.43K | ﹤0.01% | 3066 |
|
|
2019
Q3 | $614K | Buy |
15,535
+7,367
| +90% | +$291K | ﹤0.01% | 3506 |
|
|
2019
Q2 | $827K | Buy |
8,168
+965
| +13% | +$97.7K | ﹤0.01% | 3419 |
|
|
2019
Q1 | $947K | Buy |
7,203
+1,638
| +29% | +$215K | ﹤0.01% | 3376 |
|
|
2018
Q4 | $567K | Sell |
5,565
-276
| -5% | -$28.1K | ﹤0.01% | 3525 |
|
|
2018
Q3 | $1.46M | Buy |
5,841
+755
| +15% | +$189K | ﹤0.01% | 3359 |
|
|
2018
Q2 | $2.27M | Buy |
5,086
+619
| +14% | +$276K | ﹤0.01% | 3138 |
|
|
2018
Q1 | $1.76M | Buy |
4,467
+2,350
| +111% | +$926K | ﹤0.01% | 3171 |
|
|
2017
Q4 | $870K | Buy |
2,117
+588
| +38% | +$242K | ﹤0.01% | 3439 |
|
|
2017
Q3 | $661K | Buy |
+1,529
| New | +$661K | ﹤0.01% | 3528 |
|